Corona Virus Disease 2019 (COVID-19) and Its Effect on Renal System, A Systematic Review and Meta-analysis

Mehrbod Vakhshoori, Sayed Ali Emami, Maryam Heidarpour

  • 1Heart Failure Research Center, Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran. d.shafie87@gmail.com.

Insights

COVID-19 (Coronavirus disease 2019) rarely causes severe kidney problems. Acute kidney injury (AKI) was infrequent, particularly in non-severe cases, suggesting limited renal involvement in most patients.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Internal Medicine

Background:

  • Coronavirus disease 2019 (COVID-19) primarily affects the respiratory system but can involve other organs.
  • Acute kidney injury (AKI) is a reported complication of COVID-19, with variable reported frequencies.
  • Renal biomarkers such as blood urea nitrogen (BUN) and serum creatinine (Cr) are used to assess kidney function.

Purpose of the Study:

  • To determine the frequency of AKI in COVID-19 patients.
  • To evaluate BUN and serum Cr levels in individuals with COVID-19 infection.
  • To compare renal involvement across different clinical statuses (severe, non-severe, death).

Main Methods:

  • A systematic literature review was conducted across Medline/PubMed, Scopus, and Google Scholar until April 16, 2020.
  • Included peer-reviewed studies on COVID-19 patients, with no language restrictions.
  • Patients were categorized into severe, non-severe, and death groups for comparative analysis.

Main Results:

  • 18 records involving 4528 individuals were analyzed. The mean age was 52.5 years (55.6% male).
  • Overall AKI prevalence was 4% (95% CI: 2% to 8%), significantly lower in non-severe (1%) versus deceased (31%) patients.
  • Mean BUN was 5.14 mmol/L and mean serum Cr was 71.60 mmol/L, with lower BUN levels observed in non-severe cases compared to severe or deceased patients.

Conclusions:

  • COVID-19 appears to have limited extensive involvement of the renal system.
  • AKI incidence is low, especially in non-severe COVID-19 cases.
  • Further research into potential underlying mechanisms of renal involvement is warranted.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
576
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
367
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
277
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
156
Renal Drug Clearance: Overview01:06

Renal Drug Clearance: Overview

Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
518
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
312